In a recent study by Saarinen et al. (2024), it was demonstrated that men with metabolic syndrome who had high-sensitive C-reactive protein (hs-CRP) of more than 1.0 mg/L had a higher risk for CVD and all-cause mortality than those with hs-CRP of less than 1.0 mg/L [21]. This evidence concerns the gene CRP and metabolic syndrome.